Tan et al., 1996 - Google Patents
Identification of a Plasmodium berghei antigen sharing common features with P. falciparum and P. chabaudi parasitophorous-vacuole membrane antigensTan et al., 1996
- Document ID
- 7871007820853802602
- Author
- Tan T
- Goh K
- Binh L
- Ting R
- Kara U
- Publication year
- Publication venue
- Parasitology research
External Links
Snippet
On the basis of immunological cross-reactivity, we identified a 43-kDa Plasmodium berghei antigen with homology to the exp-1 antigen from P. falciparium. The P. berghei antigen was recognized by an antibody directed against an epitope on the C-terminus of the P …
- 239000000427 antigen 0 title abstract description 40
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morris et al. | Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell | |
| Hatch | Competition between Chlamydia psittaci and L cells for host isoleucine pools: a limiting factor in chlamydial multiplication | |
| EP1601688A2 (en) | Genes of an otitis media isolate of nontypeable haemophilus influenzae | |
| EP1287024B1 (en) | Virulence genes, proteins, and their use | |
| Ohkusu et al. | Elucidation of the protein kinase C‐dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL‐lpr/lpr mice | |
| Deplazes et al. | Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDS | |
| US5534413A (en) | Adherent and invasive mycoplasma | |
| Quanquin et al. | Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4+ T-cell-dependent parasiticidal activity | |
| AU611630B2 (en) | Detection and differentiation of coxiella burnetii in biological fluids | |
| Tan et al. | Identification of a Plasmodium berghei antigen sharing common features with P. falciparum and P. chabaudi parasitophorous-vacuole membrane antigens | |
| RU2198178C2 (en) | Peptide-immunoregulator (versions), medicinal agent comprising peptide-immunoregulator | |
| Sudheesh et al. | Sortase inhibitor phenyl vinyl sulfone inhibits Renibacterium salmoninarum adherence and invasion of host cells | |
| JP2003533990A (en) | Polypeptides having a polymorphism in the pertactin repetitive region of B. pertussis, B. parapertussis and B. bronchiseptica and their use in diagnostic and immunogenic compositions | |
| Boyer et al. | TNF and type I IFN induction of the IRG1-itaconate pathway restricts Coxiella burnetii replication within mouse macrophages | |
| Benamri et al. | Genes and mutations involved in the resistance of chlamydia species to antibiotics: a literature review | |
| EP1508572A1 (en) | PROTEIN INDUCING CELL DEATH OF i HELICOBACTER PYLORI /i | |
| Gokce et al. | Production of Tumour Necrosis Factor-alpha (TNF-α) and Reactive Nitrogen Intermediates by Ovine Peripheral Blood Leucocytes Stimulated by Ehrlichia (Cytoecetes) phagocytophila | |
| JPH11235178A (en) | Novel murb | |
| EP0247873A2 (en) | Bacteriocins and compositions thereof in anti-viral treatment | |
| JPH11151091A (en) | New aroa | |
| KR100515767B1 (en) | HlyU, Regulator of in vivo expressed virulence factors of Vibrio vulnificus | |
| KR20230159560A (en) | Compositions and methods for inhibiting the growth of enterotoxigenic Bacteroides fragilis | |
| JP2002540758A (en) | AMA | |
| JPH11151098A (en) | New his5 | |
| Rajaram | A STUDY OF HOST-CHLAMYDIAL INTERACTIONS MEDIATED BY INTERFERON-GAMMA AND NITRIC OXIDE |